Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (<scp>CML‐CP</scp>) in the tyrosine kinase inhibitor (<scp>TKI</scp>) era—Two decades of experience from the Tata Memorial Hospital paediatric <scp>CML</scp> (<scp>pCML</scp>) cohort

Nirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, Jayesh Agiwale, Kriti Hegde, Gaurav Chatterjee, Chetan Dhamne, Maya Prasad, Akanksha Chichra, Shyam Srinivasan, Purvi Mohanty, Hemani Jain, Dhanlaxmi Shetty, Prashant Tembhare, Nikhil Patkar, Gaurav Narula, Papagudi G. Subramanian, Shripad Banavali

Open source

DOI: 10.1111/bjh.19251
Published: 2023-12-14
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.19251,
  title = {Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (<scp>CML‐CP</scp>) in the tyrosine kinase inhibitor (<scp>TKI</scp>) era—Two decades of experience from the Tata Memorial Hospital paediatric <scp>CML</scp> (<scp>pCML</scp>) cohort},
  author = {Nirmalya Roy Moulik and Swaminathan Keerthivasagam and Ankita Pandey and Jayesh Agiwale and Kriti Hegde and Gaurav Chatterjee and Chetan Dhamne and Maya Prasad and Akanksha Chichra and Shyam Srinivasan and Purvi Mohanty and Hemani Jain and Dhanlaxmi Shetty and Prashant Tembhare and Nikhil Patkar and Gaurav Narula and Papagudi G. Subramanian and Shripad Banavali},
  year = {2023},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.19251},
  url = {https://doi.org/10.1111/bjh.19251}
}

RIS

TY  - JOUR
TI  - Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (<scp>CML‐CP</scp>) in the tyrosine kinase inhibitor (<scp>TKI</scp>) era—Two decades of experience from the Tata Memorial Hospital paediatric <scp>CML</scp> (<scp>pCML</scp>) cohort
AU  - Nirmalya Roy Moulik
AU  - Swaminathan Keerthivasagam
AU  - Ankita Pandey
AU  - Jayesh Agiwale
AU  - Kriti Hegde
AU  - Gaurav Chatterjee
AU  - Chetan Dhamne
AU  - Maya Prasad
AU  - Akanksha Chichra
AU  - Shyam Srinivasan
AU  - Purvi Mohanty
AU  - Hemani Jain
AU  - Dhanlaxmi Shetty
AU  - Prashant Tembhare
AU  - Nikhil Patkar
AU  - Gaurav Narula
AU  - Papagudi G. Subramanian
AU  - Shripad Banavali
PY  - 2023
JO  - British Journal of Haematology
DO  - 10.1111/bjh.19251
UR  - https://doi.org/10.1111/bjh.19251
ER  -

APA

Moulik, N. R., Keerthivasagam, S., Pandey, A., Agiwale, J., Hegde, K., Chatterjee, G., Dhamne, C., Prasad, M., Chichra, A., Srinivasan, S., Mohanty, P., Jain, H., Shetty, D., Tembhare, P., Patkar, N., Narula, G., Subramanian, P. G., & Banavali, S. (2023). Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (<scp>CML‐CP</scp>) in the tyrosine kinase inhibitor (<scp>TKI</scp>) era—Two decades of experience from the Tata Memorial Hospital paediatric <scp>CML</scp> (<scp>pCML</scp>) cohort. British Journal of Haematology. https://doi.org/10.1111/bjh.19251

Source records

crossref · retrieved 2026-09-24T22:45:46.602Z